About: Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1995 (uk) im August 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1995 (ast) scientific article published on 01 August 1995 (en)
publication date	wds:Q71961902-CEF854E4-5A50-4CB5-8EA4-065AE6DECEA7
publication date	1995-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71961902-E8807A4D-D630-4C74-95BD-DA41BEA28060
language of work or name	English
author name string	wds:Q71961902-0CC0E427-B6BE-44D1-A030-D1F3A6436C83 wds:Q71961902-20CD73C3-0358-4ACE-998F-BDCB49A48AA5 wds:Q71961902-46DCB906-7628-426F-ACC2-C913264A4F82 wds:Q71961902-4B6C38C9-6A13-4D9B-A248-24BF37EA8AD7 wds:Q71961902-50B30301-157F-4E87-A4E4-3F3E32C8443D wds:Q71961902-8C058F18-3535-4EEE-9AD6-81701C33B215 wds:Q71961902-A884864B-81D6-43FD-8B69-07B1202F9CEC wds:Q71961902-D5331764-7417-4E50-9541-1450B86386B5
author name string	B A Murphy A P Albino L Schwartz D M Nanus R J Motzer A D Hoffman T M Law V Vlamis
rdfs:label	Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (en) Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (nl)
skos:prefLabel	Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (en) Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (nl)
name	Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (en) Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (nl)
title	wds:Q71961902-91120CD9-279F-42B0-A59B-F7A126A3B32A
title	Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro (en)
page(s)	wds:Q71961902-F4BF94DB-6F92-409D-B061-02AAD1B9EB48
page(s)	1950-1957
instance of	wds:Q71961902-C4037F6A-3C5C-4F01-BD64-AB05386F44B9
instance of	scholarly article
main subject	wds:Q71961902-1AEE3112-2110-4DF6-9785-BEB5ECA51BB8 wds:Q71961902-2D77F6D0-2794-4FB1-BB38-0933521715AB
main subject	renal cell carcinoma phase II clinical trial
PubMed ID	wds:Q71961902-B5AE1DD4-42B9-49D7-9A9C-CE8F8504289E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7636535
PubMed ID	7636535
published in	wds:Q71961902-106F5500-3D2A-4E9C-8422-145AC08F2D9C
published in	Journal of Clinical Oncology
issue	wds:Q71961902-60418E18-047B-4C65-A30F-026C562C4D72
volume	wds:Q71961902-170D4FA2-66FB-4C6F-9248-EF468D465653
issue	8
volume	13
DOI	wds:Q71961902-B60645D6-FE11-4405-AC85-71CD72857FBF
DOI	http://dx.doi.org/10.1200/JCO.1995.13.8.1950
DOI	10.1200/JCO.1995.13.8.1950
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71961902
is cites work of	Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma Honey induces apoptosis in renal cell carcinoma Renal cell carcinoma Cytokine therapy in renal cell cancer Phase II trial of fenretinide in advanced renal carcinoma Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study Synthesis and biological activity of retinoic acid receptor-alpha specific amides All-trans-retinoic acid-dependent inhibition of E-cadherin-based cell adhesion with concomitant dephosphorylation of beta-catenin in metastatic human renal carcinoma cells. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation. Fine needle aspiration of renal cortical lesions in adults Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity Capecitabine in the treatment of metastatic renal cell carcinoma A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer All-trans retinoic acid enhances gap junctional intercellular communication among renal epithelial cells in vitro treated with renal carcinogens. Enhancement of fractionated-dose irradiation by retinoic acid plus interferon Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer [Oncology '96] Thirteen-year, long-term efficacy of interferon 2alpha and interleukin 2-based home therapy in patients with advanced renal cell carcinoma All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group A study exploring critical pathways in clear cell renal cell carcinoma New treatment approaches for metastatic renal cell carcinoma Chemotherapeutic strategies for renal cell carcinoma A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma Advanced renal cell carcinoma Cytokines and cell regulation. Cytokine-based therapy for metastatic renal cell cancer Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma The Evaluation and Comparing of Cytotoxic Effects of Ferula gummosa Gum, Scutellaria lindbergii, Kelussia odoratissima and Artemisia kopetdaghensis Extracts on ACHN Cell Line Systemic treatment of neoplastic conditions with retinoids. Evaluation of steroid hormones and their receptors in development and progression of renal cell carcinoma. Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma Retinol (vitamin A) supplements in the elderly Does addition of 13-cis-retinoic acid to interferon-alpha2a improve survival in patients with metastatic RCC?
is cites work of	wds:Q34739064-85888912-0428-4007-B72F-354CA0F71E43 wds:Q52536769-E820D0EB-D904-4176-9B30-D68F5455A5C0 wds:Q73315349-7D989017-A754-4D8E-85B7-F8A379CD0307 wds:Q35211001-C6540522-2F33-44CD-8525-DBAB0FE53F01 wds:Q34678045-AD647511-C32F-4290-A52B-EFDAA5051D31 wds:Q34415906-08025408-CFF2-42E5-8FB6-5CA99EC70C64 wds:Q36621825-938512F5-017B-4308-BE17-64BB7407F3CC wds:Q42704500-C98AAF73-5FA6-4238-B310-A035B1C6B4E2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software